Physician

Matthew Alfred Speicher, M.D.

According to 2025 Medicare claims, Matthew Speicher, M.D. (NPI: 1275536963) practices ophthalmology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 17331-1587. Speicher is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Speicher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,071 traditional Medicare patients, billed 23,904 HCPCS/CPT codes, and received $4,416,434 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 246 prescription claims across 88 beneficiaries totaling $15,969 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 29 records totaling $1,034. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,395,333 to $4,416,434. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	893	12,388	$2,395,333
2016	900	11,247	$2,022,118
2017	934	12,933	$2,360,028
2018	1,025	13,440	$2,710,106
2019	1,050	15,246	$3,160,303
2020	967	12,878	$2,768,729
2021	1,030	13,966	$3,043,011
2022	994	13,935	$3,046,595
2023	1,120	19,418	$3,731,180
2024	1,071	23,904	$4,416,434

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	189	$16,074
2016	77	208	$15,843
2017	82	254	$21,470
2018	79	217	$15,961
2019	78	303	$18,930
2020	72	270	$19,766
2021	69	224	$17,097
2022	63	206	$16,579
2023	76	213	$14,946
2024	88	246	$15,969

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	418	1,822	$94
92014	Established patient complete exam of visual system	937	2,580	$89
92134	Imaging of retina	560	1,755	$31
92250	Photography of the retina	803	1,038	$27
92202	Extended exam of the back part of the eye with optic nerve drawing	272	580	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Combigan	Brimonidine Tartrate/Timolol	14	570	$4,192
Bromfenac Sodium	Bromfenac Sodium	36	1,027	$4,119
Prednisolone Acetate	Prednisolone Acetate	87	3,063	$3,804
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	698	$1,733
Moxifloxacin	Moxifloxacin Hcl	12	137	$304

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$1,034	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Alfred Speicher, M.D.?

Tedicare shows public-source Medicare data for Matthew Alfred Speicher, M.D. (NPI 1275536963), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Alfred Speicher, M.D. have ACO affiliation data?

Matthew Alfred Speicher, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Matthew Alfred Speicher, M.D.?

Matthew Alfred Speicher, M.D. is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Matthew Alfred Speicher, M.D. have Open Payments data?

Matthew Alfred Speicher, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.